Literature DB >> 18601763

Laparoscopic diagnosis and treatment of nonpalpable testis.

Francisco T Denes1, Fernando J Saito, Frederico A Silva, Amilcar M Giron, Marcos Machado, Miguel Srougi.   

Abstract

INTRODUCTION: Treatment of the cryptorchid testicle is justified due to the increased risk of infertility and malignancy as well as the risk of testicular trauma and psychological stigma on patients and their parents. Approximately 20% of cryptorchid testicles are nonpalpable. In these cases, the videolaparoscopic technique is a useful alternative method for diagnosis and treatment.
MATERIALS AND METHODS: We present data concerning 90 patients submitted to diagnostic laparoscopy for impalpable testicles. Forty-six patients (51.1%) had intra-abdominal gonads. In 25 testicles of 19 patients, we performed a two stage laparoscopic Fowler-Stephens orchiopexy. The other 27 patients underwent primary laparoscopic orchiopexy, in a total of 29 testicles.
RESULTS: We obtained an overall 88% success rate with the 2 stage Fowler-Stephens approach and only 33% rate success using one stage Fowler-Stephens surgery with primary vascular ligature. There was no intraoperative complication in our group of patients. In the laparoscopic procedures, the cosmetic aspect is remarkably more favorable as compared to open surgeries. Hospital stay and convalescence were brief.
CONCLUSIONS: In pediatric age group, the laparoscopic approach is safe and feasible. Furthermore, the laparoscopic orchiopexy presents excellent results in terms of diagnosis and therapy of the impalpable testis, which is why this technique has been routinely incorporated in our Department.

Entities:  

Mesh:

Year:  2008        PMID: 18601763     DOI: 10.1590/s1677-55382008000300010

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  18 in total

Review 1.  What is the ideal surgical approach for intra-abdominal testes? A systematic review.

Authors:  Carolyn Wayne; Emily Chan; Ahmed Nasr
Journal:  Pediatr Surg Int       Date:  2015-02-08       Impact factor: 1.827

2.  Canadian Urological Association-Pediatric Urologists of Canada (CUA-PUC) guideline for the diagnosis, management, and followup of cryptorchidism.

Authors:  Luis H Braga; Armando J Lorenzo; Rodrigo L P Romao
Journal:  Can Urol Assoc J       Date:  2017-07-11       Impact factor: 1.862

3.  Current Management of Undescended Testes.

Authors:  David Kurz
Journal:  Curr Treat Options Pediatr       Date:  2016-01-25

4.  Diagnostic imaging in cryptorchidism: utility, indications, and effectiveness.

Authors:  Gregory E Tasian; Hillary L Copp; Laurence S Baskin
Journal:  J Pediatr Surg       Date:  2011-12       Impact factor: 2.545

Review 5.  Current management of non-palpable testes: a literature review and clinical results.

Authors:  Ximena Sepúlveda; Pedro-José López Egaña
Journal:  Transl Pediatr       Date:  2016-10

Review 6.  Diagnostic performance of ultrasound in nonpalpable cryptorchidism: a systematic review and meta-analysis.

Authors:  Gregory E Tasian; Hillary L Copp
Journal:  Pediatrics       Date:  2010-12-13       Impact factor: 7.124

7.  Laparoscopy-assisted cutaneous ureterostomy at suprapubic creaseline facilitates subsequent reimplantation.

Authors:  Md Jafrul Hannan
Journal:  J Minim Access Surg       Date:  2015 Apr-Jun       Impact factor: 1.407

Review 8.  The Nonpalpable Testis: A Narrative Review.

Authors:  Courtney L Shepard; Kate H Kraft
Journal:  J Urol       Date:  2017-04-21       Impact factor: 7.450

Review 9.  Effectiveness of hormonal and surgical therapies for cryptorchidism: a systematic review.

Authors:  David Penson; Shanthi Krishnaswami; Astride Jules; Melissa L McPheeters
Journal:  Pediatrics       Date:  2013-05-20       Impact factor: 7.124

10.  Evaluation of two-staged Fowler-Stephens laparoscopic orchidopexy (FSLO) for intra-abdominal testes (IAT).

Authors:  Deepak Bagga; Ashish Prasad; Shabnam Bhandari Grover; Nidhi Sugandhi; Narender Tekchandani; Samir Kant Acharya; Amat Samie
Journal:  Pediatr Surg Int       Date:  2017-10-04       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.